Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas

Journal of Nuclear Medicine

Volumn 55, Issue 3, 2014, Pages 460-465

  Eriksson, Olof ^a   Selvaraju, Ram K ^a   Johansson, Lars ^a,b   Eriksson, Jan W ^a,b   Sundin, Anders ^c   Antoni, Gunnar ^a   Sörensen, Jens ^a   Eriksson, Barbro ^a   Korsgren, Olle ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 Hydroxy tryptophan; Beta cell imaging; Diabetes; Serotonin biosynthesis

Indexed keywords

5 HYDROXYTRYPTOPHAN C 11; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; RADIOPHARMACEUTICAL AGENT; SEROTONIN; UNCLASSIFIED DRUG; 5 HYDROXYTRYPTOPHAN; AMINE OXIDASE (FLAVIN CONTAINING); CARBON; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE CELL; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INS1 CELL LINE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MONOAMINE METABOLISM; NONHUMAN; PANC1 CELL LINE; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SEROTONIN SYNTHESIS; 5-HYDROXY TRYPTOPHAN; ANIMAL; BETA CELL IMAGING; CELL LINE; DIABETES MELLITUS; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

5-HYDROXY TRYPTOPHAN; BETA CELL IMAGING; DIABETES; SEROTONIN BIOSYNTHESIS;

5-HYDROXYTRYPTOPHAN; ANIMALS; CARBON RADIOISOTOPES; CELL LINE; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MONOAMINE OXIDASE; POSITRON-EMISSION TOMOGRAPHY; RATS; SEROTONIN;

EID: 84899482953     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.125187     Document Type: Article

References (18)

1. Maffei A, Liu Z, Witkowski P, et al. Identification of tissue-restricted transcripts in human islets. Endocrinology. 2004;145:4513-4521.
2. Simpson NR, Souza F, Witkowski P, et al. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol. 2006;33:855-864.
3. Paulmann N, Grohmann M, Voigt JP. et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009;7:e1000229.
4. Ohta Y, Kosaka Y, Kishimoto N, et al. Convergence of the insulin and serotonin programs in the pancreatic beta-cell. Diabetes. 2011;60:3208-3216.
5. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16:804-808.
6. Lundquist P, Blomquist G, Hartvig P, et al. Validation studies on the 5-hydroxy- L-[beta-11C]-tryptophan/PET method for probing the decarboxylase step in serotonin synthesis. Synapse. 2006;59:521-531.
7. Orlefors H, Sundin A, Ahlstrom H, et al. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors. J Clin Oncol. 1998;16:2534- 2541. (Pubitemid 28309052)
8. Orlefors H, Sundin A, Garske U, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab. 2005;90:3392-3400.
9. Ekholm R, Ericson LE, Lundquist I. Monoamines in the pancreatic islets of the mouse: subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia. 1971;7:339-348.
10. Di Gialleonardo V, Signore A, Scheerstra EA, et al. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med. 2012;53:1755- 1763.
11. Goto M, Eich TM, Felldin M, et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation. 2004;78:1367-1375.
12. Orlefors H, Sundin A, Lu L, et al. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5- hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:60-65.
13. Daidone F, Montioli R, Paiardini A, et al. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. PLoS ONE. 2012; 7:e31610.
14. Selvaraju RK, Velikyan I, Johansson L, et al. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. J Nucl Med. 2013;54:1458-1463.
15. Tornehave D, Kristensen P, Rømer J, et al. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem. 2008;56:841-851.
16. Van der Weg W, Brom M, Janssen MJR, et al. 111In-exendin for non-invasive quantification of beta cell mass in patients with type 1 diabetes and healthy controls [abstract]. Diabetologia. 2013;56(suppl):5080.
17. Nordberg A, Rinne JO, Kadir A, et al. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6:78-87.
18. Eriksson O, Selvaraju RK, Borg B, et al. 5-fluoro-[b-11C]-L-tryptophan is a functional analogue of 5-hydroxy-[b-11C]-L-tryptophan in vitro but not in vivo. Nucl Med Biol. 2013;40:567-575.